參考文獻(xiàn)/References:
[1] 中國(guó)中醫(yī)藥研究促進(jìn)會(huì)骨傷科分會(huì).膝骨關(guān)節(jié)炎中醫(yī)診療指南(2020年版)[J].中醫(yī)正骨,2020,32(10):1-14.
[2] JONES I A,TOGASHI R,WILSON M L,et al.Intra-articular treatment options for knee osteoarthritis[J].Nat Rev Rheumatol,2019,15(2):77-90.
[3] RHEE J,PARK S H,KIM S K,et al.Inhibition of BATF/JUN transcriptional activity protects against osteoarthritic cartilage destruction[J].Ann Rheum Dis,2017,76(2):427-434.
[4] CHOI M C,JO J,PARK J,et al.NF-κB signaling pathways in osteoarthritic cartilage destruction[J].Cells,2019,8(7):734.
[5] 袁普衛(wèi),李小群,康武林,等.蠲痹膠囊對(duì)膝骨關(guān)節(jié)炎豚鼠關(guān)節(jié)軟骨組織形態(tài)及滑膜中Toll樣受體4、NF-κB p65及腫瘤壞死因子-α表達(dá)的影響[J].中醫(yī)正骨,2016,28(9):5-12.
[6] AQDAS M,SUNG M H.NF-κB dynamics in the language of immune cells[J].Trends Immunol,2023,44(1):32-43.
[7] SAITO T,TANAKA S.Molecular mechanisms underlying osteoarthritis development:Notch and NF-κB[J].Arthritis Res Ther,2017,19(1):94.
[8] GLOIRE G,PIETTE J.Redox regulation of nuclear post-translational modifications during NF-kappaB activation,antioxid[J]Antioxid Redox Signal,2009,11(9):2209-2222.
[9] OECKINGHAUS A,HAYDEN M S,GHOSH S.Crosstalk in NF-κB signaling pathways[J].Nat Immunol,2011,12(8):695-708.
[10] EVERS B J,VAN DEN BOSCH M H J,BLOM A B,et al.Post-traumatic knee osteoarthritis; the role of inflammation and hemarthrosis on disease progression[J].Front Med(Lausanne),2022,9:973870.
[11] YU Y W,LI S Y,ZHANG L J,et al.Retinoic acid receptor gamma(RAR)promotes cartilage destruction through positive feedback activation of NF-B pathway in human osteo-arthritis[J].Mediators Inflamm,2022:1875736.
[12] ZHENG W,TAO Z,CAI L,et al.Chrysin attenuates IL-1β-Induced expression of inflammatory mediators by suppressing NF-κB in human osteoarthritis chondrocytes[J].Inflammation,2017,40(4):1143-1154.
[13] XUE H,TU Y,MA T,et al.MiR-93-5p attenuates IL-1β-induced chondrocyte apoptosis and cartilage degradation in osteoarthritis partially by targeting TCF4[J].Bone,2019,123:129-136.
[14] HU Y,CHEN X,WANG S,et al.Subchondral bone microenvironment in osteoarthritis and pain[J].Bone Res,2021,9(1):20.
[15] ZHAO C,LIU Q,WANG K.Artesunate attenuates ACLT-induced osteoarthritis by suppressing osteoclastogenesis and aberrant angiogenesis[J].Biomed Pharmacother,2017,96:410-416.
[16] WU Z,YUAN K,ZHANG Q,et al.Antioxidant PDA-PEG nanoparticles alleviate early osteoarthritis by inhibiting osteoclastogenesis and angiogenesis in subchondral bone[J].J Nanobiotechnology,2022,20(1):479.
[17] ZHU M,SHAN J,XU H,et al.Glaucocalyxin a suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways[J].J Ethnopharmacol,2021,276(2):114176.
[18] LIU C,HE Y,XU X,et al.The study of natural compounds targeting RANKL signaling pathway for the treatment of bone diseases[J].Curr Drug Targets,2020,21(4):344-357.
[19] NYGAARD G,FIRESTEIN G S.Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes[J].Nat Rev Rheumatol,2020,16(6):316-333.
[20] NISHIYAMA S,HIROSE N,YANOSHITA M,et al.ANGPTL2 induces synovial inflammation via LILRB2[J].Inflammation,2021,44(3):1108-1118.
[21] LIU-BRYAN R,TERKELTAUB R.Emerging regulators of the inflammatory process inosteoarthritis[J].Nat Rev Rheumatol,2015,11(1):35-44.
[22] SUANTAWEE T,TANTAVISUT S,ADISAKWATTANA S,et al.Upregulation of inducible nitric oxide synthase and nitrotyrosine expression in primary knee osteoarthritis[J].J Med Assoc Thai,2015,98(Suppl 1):S91-97.
[23] HOU S M,HOU C H,LIU J F.CX3CL1 promotes MMP-3 production via the CX3CR1,c-Raf,MEK,ERK,and NF-κB signaling pathway in osteoarthritis synovial fibroblasts[J].Arthritis Res Ther,2017,19(1):282.
[24] 安方玉,顏春魯,張艷霞,等.右歸丸對(duì)膝骨關(guān)節(jié)炎大鼠PI3K/Akt/NF-κB信號(hào)通路的影響[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2019,12(5):479-487.
[25] 金連峰,顧煒,劉子聞,等.基于TLR4/MyD88/NF-κB信號(hào)通路探討左、右歸丸影響骨關(guān)節(jié)炎模型的作用機(jī)制研究[J/OL].中華中醫(yī)藥學(xué)刊,2023[2023-04-04].https://kns.cnki.net/kcms/detail/21.1546.R.20230517.1742.016.html.
[26] 劉海龍,王鋼,王佳,等.補(bǔ)腎通絡(luò)方抑制NF-κB/RANK/RANKL通路減輕膠原蛋白誘導(dǎo)關(guān)節(jié)炎(CIA)大鼠骨破壞[J].細(xì)胞與分子免疫學(xué)雜志,2021,37(3):205-211.
[27] 陳寶軍,閆虎,張慶,等.壯骨健膝方治療肝腎虧虛、風(fēng)寒濕痹型膝骨關(guān)節(jié)炎76例臨床觀察[J].福建中醫(yī)藥大學(xué)學(xué)報(bào),2013,23(6):3-5.
[28] 陳鵬,郭潔梅,肖艷,等.基于LXRs/NF-κB信號(hào)通路對(duì)A型滑膜細(xì)胞的調(diào)控探討壯骨健膝方的作用機(jī)制[J].中國(guó)中西醫(yī)結(jié)合雜志,2022,42(9):1087-1094.
[29] 錢(qián)佳佳,許奇,許煒民,等.溫經(jīng)通絡(luò)湯對(duì)膝骨關(guān)節(jié)炎模型小鼠膝關(guān)節(jié)軟骨組織HMGB1/NF-κB信號(hào)通路的影響[J].中醫(yī)雜志,2023,64(9):939-947.
[30] 錢(qián)凱,鄭雪霞,李海鴻,等.甘草附子湯調(diào)控NF-κB信號(hào)通路抑制膠原誘導(dǎo)型關(guān)節(jié)炎小鼠骨質(zhì)破壞的作用[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2022,28(23):1-9.
[31] 趙杰,蘇啟表,李之琛,等.甘草附子湯對(duì)膝關(guān)節(jié)骨關(guān)節(jié)炎大鼠NF-κB信號(hào)通路的影響[J].廣東藥科大學(xué)學(xué)報(bào),2022,38(6):68-73.
[32] 胡鋒,胡小軍,李建偉,等.三仁湯調(diào)控骨關(guān)節(jié)炎大鼠關(guān)節(jié)疼痛和軟骨損傷機(jī)制研究[J].時(shí)珍國(guó)醫(yī)國(guó)藥,2022,33(6):1348-1350.
[33] WANG X,FAN J,DING X,et al.Tanshinone I inhibits IL-1β-induced apoptosis,inflammation and extracellular matrix degradation in chondrocytes CHON-001 cells and attenuates murine osteoarthritis[J].Drug Des Devel Ther,2019,13:3559-3568.
[34] 張金鋒,徐志龍,吳夢(mèng),等.丹參酮ⅡA通過(guò)抑制信號(hào)通路延緩膝骨關(guān)節(jié)炎大鼠軟骨退變及抑制局部炎癥的研究[J].中國(guó)藥學(xué)雜志,2021,56(23):1918-1926.
[35] 陳譜,阮安民,周俊,等.基于NF-κB信號(hào)通路探討芍藥苷對(duì)LPS誘導(dǎo)的人軟骨細(xì)胞炎癥及退變的作用機(jī)制[J].北京中醫(yī)藥大學(xué)學(xué)報(bào),2020,43(11):903-909.
[36] 李寧博,駱曉飛,尹夏,等.杜仲多糖通過(guò)抑制NF-κB通路減輕IL-1β誘導(dǎo)的軟骨細(xì)胞損傷[J].中國(guó)骨傷,2022,35(7):661-668.
[37] JIANG C,SUN Z M,HU J N,et al.Cyanidin ameliorates the progression of osteoarthritis via the Sirt6/NF-κB axis in vitro and in vivo[J].Food Funct,2019,10(9):5873-5885.
[38] 胡芯源,曹珊,陳文明,等.連翹苷元通過(guò)抑制TLR4介導(dǎo)的NF-κB信號(hào)通路減輕大鼠骨關(guān)節(jié)炎軟組織損傷和基質(zhì)降解[J].免疫學(xué)雜志,2021,37(2):115-121.
相似文獻(xiàn)/References:
[1]孟維娜,明立功,王新德,等.關(guān)節(jié)鏡下清理聯(lián)合腓骨近1/3段截骨治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(11):40.
[2]明立功,孟維娜,王新德,等.腓骨近端截骨治療內(nèi)側(cè)間室膝骨關(guān)節(jié)炎的近期療效觀察[J].中醫(yī)正骨,2015,27(10):25.
[3]張杰,王人彥,張玉柱.膝骨關(guān)節(jié)炎的治療進(jìn)展[J].中醫(yī)正骨,2015,27(10):68.
[4]梁朝,蔡靜怡,閆立,等.針刀療法改善膝骨關(guān)節(jié)炎早期疼痛癥狀的療效評(píng)價(jià)[J].中醫(yī)正骨,2015,27(09):9.
LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):9.
[5]王建武,黨建軍,李強(qiáng),等.四聯(lián)療法治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(08):44.
[6]劉紅娟,郭會(huì)利,郭樹(shù)農(nóng).云克聯(lián)合中藥治療膝骨關(guān)節(jié)炎的護(hù)理[J].中醫(yī)正骨,2015,27(08):75.
[7]陳衛(wèi)衡.探索建立系統(tǒng)的膝骨關(guān)節(jié)炎中醫(yī)臨床科研范式
和理論體系[J].中醫(yī)正骨,2015,27(07):1.
[8]鄭春松,葉蕻芝,李西海,等.透骨消痛膠囊中補(bǔ)腎柔肝藥和活血祛風(fēng)藥治療
骨關(guān)節(jié)炎作用方式的計(jì)算機(jī)模擬比較[J].中醫(yī)正骨,2015,27(07):6.
ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(補(bǔ)腎柔肝)drugs versus Huoxue Qufeng(活血祛風(fēng))drugs contained in Tougu Xiaotong Jiaonang(透骨消痛膠囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):6.
[9]帥波,沈霖,楊艷萍,等.加味青娥丸治療膝骨關(guān)節(jié)炎的作用機(jī)制研究[J].中醫(yī)正骨,2015,27(07):15.
SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):15.
[10]梅其杰,袁長(zhǎng)深,段戡,等.壯藥骨痹方燙熨聯(lián)合運(yùn)動(dòng)療法治療膝骨關(guān)節(jié)炎的臨床研究[J].中醫(yī)正骨,2015,27(07):27.
MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):27.